Potential for synthesis and degradation of extracellular matrix proteins by valve interstitial cells seeded onto collagen scaffolds.

Matrix remodeling, which involves proteolytic enzymes, such as the matrix metalloproteinases (MMPs), is of significant importance with respect to tissue engineering a heart valve construct. The ability of valve interstitial cells (ICs) to release these enzymes in biological scaffolds and to synthesize their own matrix has not been adequately studied, and this has important implications for tissue engineering. Cultured human aortic valve ICs were seeded onto a 3-dimensional type I collagen matrix for 28 days, whereby the presence of the remodeling enzymes, MMPs, were determined using immunohistochemistry, and detection of extracellular matrix (ECM) gene expression was performed using in situ hybridization. The collagenases, stromelysins, and membrane-type MMPs were expressed in 1%, 2%, and 5% collagen scaffolds after 28 days, whereas gelatinase expression was not observed. In situ hybridization revealed the presence of the ECM messenger ribonucleic acid (mRNA) in cells cultured in collagen scaffolds however, an increase in all three mRNAs was only detected in the 1% collagen scaffolds. The presence of collagenases, stromelysins, and membrane-type MMPs indicate that human valve ICs have the capacity to remodel type I collagen scaffold and that the genes necessary for synthesizing matrix have been turned on within the cells themselves. Scaffold composition also demonstrated differential effects onMMPexpression. These observations are of relevance with respect to the development of tissue-engineered heart valves.

[1]  V. Joag,et al.  The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.

[2]  Eleftherios Sachlos,et al.  Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. , 2006, Biomaterials.

[3]  M. Yacoub,et al.  Extracellular matrix scaffolds for tissue engineering heart valves , 2006 .

[4]  J. Takkenberg,et al.  Will heart valve tissue engineering change the world? , 2005, Nature Clinical Practice Cardiovascular Medicine.

[5]  Frederick J Schoen,et al.  Heart valve regeneration. , 2005, Advances in biochemical engineering/biotechnology.

[6]  M. Yacoub,et al.  Regulation of ecto-5′-nucleotidase by TNF-α in human endothelial cells , 2002, Molecular and Cellular Biochemistry.

[7]  S. Curran,et al.  New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression , 2003, The Journal of pathology.

[8]  Ivan Stamenkovic,et al.  Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.

[9]  Ivan Stamenkovic,et al.  Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.

[10]  B Derby,et al.  Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. , 2003, Biomaterials.

[11]  R. Tarnuzzer,et al.  Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. , 2003, Investigative ophthalmology & visual science.

[12]  M. Kuzuya,et al.  Role of matrix metalloproteinases in vascular remodeling. , 2003, Journal of atherosclerosis and thrombosis.

[13]  Magdi H Yacoub,et al.  Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. , 2002, The Journal of heart valve disease.

[14]  Simon P. Hoerstrup,et al.  Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.

[15]  Magdi H Yacoub,et al.  Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. , 2002, The Journal of heart valve disease.

[16]  G. Fields,et al.  Matrix metalloproteinases and collagen catabolism. , 2002, Biopolymers.

[17]  L. Matrisian,et al.  Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.

[18]  B Glasmacher,et al.  In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. , 2001, The Thoracic and cardiovascular surgeon.

[19]  W. Stetler-Stevenson,et al.  Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.

[20]  H. Alexander,et al.  Development and characterization of tissue-engineered aortic valves. , 2001, Tissue engineering.

[21]  Antoon F. M. Moorman,et al.  Sensitive Nonradioactive Detection of mRNA in Tissue Sections: Novel Application of the Whole-mount In Situ Hybridization Protocol , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  S. Hoerstrup,et al.  Optimized Growth Conditions for Tissue Engineering of Human Cardiovascular Structures , 2000, The International journal of artificial organs.

[23]  F J Schoen,et al.  Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.

[24]  A Haverich,et al.  Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.

[25]  F J Schoen,et al.  Tissue engineering of heart valves: in vitro experiences. , 2000, The Annals of thoracic surgery.

[26]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[27]  J. Woessner,et al.  Matrix metalloproteinases and TIMPs , 2000 .

[28]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[29]  A. Khaghani,et al.  Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy , 1999, European journal of clinical investigation.

[30]  M. Yacoub,et al.  Ecto-5'-nucleotidase activity is reduced in the presence of TNF-alpha in human endothelial cells , 1999 .

[31]  A Haverich,et al.  Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  R Langer,et al.  Tissue-engineered heart valve leaflets: does cell origin affect outcome? , 1997, Circulation.

[33]  C K Breuer,et al.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.

[34]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[35]  M. Simionescu,et al.  Interstitial Cells of the Heart Valves Possess Characteristics Similar to Smooth Muscle Cells , 1986, Circulation research.